STACY LOWARY: Open Payments
NPI 1093274524 · QUINCY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 35 payments from 12 companies in 2025. Trend: 2023 $775 · 2024 $478 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $229 |
| Amgen Inc. | 4 | $65 |
| Novo Nordisk Inc | 2 | $48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $32 |
| Esperion Therapeutics, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $26 |
| Boston Scientific Corporation | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| HEARTFLOW, INC. | 1 | $18 |
Products named: LEQVIO, REPATHA, Wegovy, LifeVest, NEXLETOL, VYNDAMAX, WATCHMAN Access System, AMVUTTRA.
Industry payments across IL — which companies pay providers there.
